Cortellis Drug Discovery Intelligence

Speed up drug development with comprehensive discovery and preclinical insights.

Make informed R&D decisions with confidence and reduce the risk of late-stage failures.

Advance discovery and preclinical development and avoid late-stage failures with drug intelligence that integrates multi-source scientific data into one platform.

Benchmark and Optimize Drug Candidates

Evaluate your drug’s preclinical performance against prior research with integrated insights across biology, chemistry, and pharmacology—all in one platform.

Identify and Prioritize Targets & Biomarkers

Develop data-driven hypotheses for new targets, drugs, and biomarkers with intelligence spanning the entire drug discovery lifecycle, from early development to market launch.

Increase Drug Development Success

Strengthen R&D decision-making and reduce late-stage failures with a preclinical solution designed by scientists, for scientists.

Built for Scientists, by Scientists

Reliable, Enriched Data

Access accurate, up-to-date content curated through a combination of advanced technology and expert human review by scientists and subject matter experts.

Granular Indexing for Precision Search

Find exactly what you need with powerful search capabilities—filter by drug name, disease area, chemical structure, and more, using 20+ filters and deeply indexed data.

Comprehensive Scientific Coverage

Leverage an unparalleled breadth of scientific intelligence, drawing from global sources and spanning 27+ therapy areas and 6,500+ diseases, including rare conditions.

Our Impact in Numbers

Customized solutions, powered by extensive expertise in drug commercialization and healthcare, to strengthen your strategy and drive success.

100%

Coverage of U.S. population enrollment data by coverage type

2.4M+

Practitioners and their affiliations across 5,400+ health systems

6K+

U.S. hospitals’ diagnosis and procedure data